Singapore & South Korea’s Recognition Of GMP Inspections To Cut Burden For Companies

A new agreement signed between Singapore’s Health Sciences Authority and South Korea’s Ministry of Food and Drug Safety means drug manufacturers in the two regions will be subjected to fewer duplicative good manufacturing practice inspections.

Handshake between South Korea and Singapore flags painted on hands, isolated transparent image.
Agreement will help save inspection resources at HSA & MFDS • Source: Shutterstock

Drug regulatory authorities in Singapore and South Korea have signed a mutual recognition agreement that will allow them to rely on each other’s good manufacturing practice (GMP) certificates and inspection outcomes relating to drug manufacturing sites in the two countries.

The MRA, signed by Singapore’s Health Sciences Authority and Korea’s Ministry of Food and Drug Safety, is expected to reduce the regulatory burden on pharmaceutical and biologics manufacturers in the two regions by

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from South Korea

More from Asia